3 C
New York
Tuesday, January 31, 2023

Analyst Expects Cybin Inc. (AMEX: CYBN) To Make Big Moves

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Cybin Inc. (CYBN) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.03, or -5.94%, to $0.53. The Cybin Inc. has recorded 97,895 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Cybin Outlines Upcoming Priorities and Milestones for its Clinical Development Programs.


Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Stocks Info

As a AMEX listed company, CYBN falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.56 and fluctuated between $0.6200 as its day high and $0.4800 as its day low. The current market capitalization of Cybin Inc. is $122.90M. A total of 4.85 million shares were traded on the day, compared to an average of 1.05M shares.

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, CYBN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 11 BUYs and 1 SELLs from insiders. Insiders purchased 1,964,410 shares during that period but sold 20,000.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for CYBN in the last 3 months, the mean price target is $4.74 with high estimates of $10.00 and low estimates of $1.12. In terms of 52-week highs and lows, CYBN has a high of $1.16 and a low of $0.26.

As of this writing, CYBN has an earnings estimate of -$0.05 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.06.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 6 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CYBN is Overweight with a score of 4.86. A total of 6 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles